Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
CALL
Canadian Natural Resources
CNQ
$99.4B
| $55.5K | ﹤0.01% |
+2,000
| New | +$57.2K |
|
|
OMIC
4352
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $55.2K | ﹤0.01% |
915
+427
| +88% | +$28.6K |
|
4353
ARK Blockchain & Fintech Innovation ETF
ARKF
$722M
| $55.2K | ﹤0.01% |
3,865
-1,890
| -33% | -$29.3K |
|
4354
US Global Investors
GROW
$35.5M
| $55.1K | ﹤0.01% |
19,083
| – | – |
|
4355
Tilly's
TLYS
$116M
| $54.9K | ﹤0.01% |
6,071
+4,769
| +366% | +$41.9K |
|
4356
Accuray
ARAY
$32M
| $54.9K | ﹤0.01% |
26,246
+413
| +2% | +$853 |
|
4357
Pure Cycle
PCYO
$253M
| $54.8K | ﹤0.01% |
5,229
+4,403
| +533% | +$41.2K |
|
4358
PUT
Ginkgo Bioworks
DNA
$528M
| $54.8K | ﹤0.01% |
810
| – | – |
|
4359
PCB Bancorp
PCB
$392M
| $54.7K | ﹤0.01% |
3,092
+2,551
| +472% | +$47.5K |
|
4360
Seanergy Maritime Holdings
SHIP
$379M
| $54.5K | ﹤0.01% |
11,000
| – | – |
|
|
SEMR
4361
DELISTED
Semrush
SEMR
| $54.5K | ﹤0.01% |
6,693
-12,000
| -64% | -$122K |
|
4362
CALL
Geron
GERN
$828M
| $54.5K | ﹤0.01% |
+22,500
| New | +$50.4K |
|
4363
CALL
Kimberly-Clark
KMB
$36.3B
| $54.3K | ﹤0.01% |
+400
| New | +$50.8K |
|
|
GTAC
4364
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
| $54.2K | ﹤0.01% |
5,270
| – | – |
|
4365
PepGen
PEPG
$122M
| $54K | ﹤0.01% |
4,038
+3,632
| +895% | +$46.9K |
|
4366
Kaltura
KLTR
$206M
| $54K | ﹤0.01% |
31,367
+27,974
| +824% | +$51.4K |
|
4367
Lifecore Biomedical
LFCR
$166M
| $53K | ﹤0.01% |
8,184
+6,992
| +587% | +$57.6K |
|
4368
Village Super Market
VLGEA
$651M
| $53K | ﹤0.01% |
2,274
+1,915
| +533% | +$42.5K |
|
4369
VEON
VEON
$3.62B
| $52.9K | ﹤0.01% |
4,320
| – | – |
|
4370
Ramaco Resources Class A
METC
$599M
| $52.9K | ﹤0.01% |
6,221
+5,238
| +533% | +$52.9K |
|
4371
ESS Tech
GWH
$22M
| $52.6K | ﹤0.01% |
1,444
+1,216
| +533% | +$62.4K |
|
4372
National Bankshares
NKSH
$259M
| $52.4K | ﹤0.01% |
1,299
+935
| +257% | +$35.1K |
|
4373
Greene County Bancorp
GCBC
$570M
| $52.3K | ﹤0.01% |
1,820
+1,532
| +532% | +$51.1K |
|
4374
Zevia
ZVIA
$122M
| $52K | ﹤0.01% |
12,717
+8,012
| +170% | +$33K |
|
4375
Norwood Financial Corp
NWFL
$370M
| $51.9K | ﹤0.01% |
1,552
+1,136
| +273% | +$34.4K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.